Oasis Trading · 66-41 · KOREA (THE REPUBLIC OF)
For Oasis Trading, import alert is 66-41; country is KOREA (THE REPUBLIC OF); import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is Festal Plus Tablets | Younggaksan Powder | Festal Plus Tablets | Younggaksan Powder; product code is 64 E - - 01 Cellulase (Enzyme) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 Y - - 99 Exhibits - Other Drug Related Items N.E.C; date published is 07/31/2019; address is 39-13 Sugi-Ro , Gocheon-Eup , Gimpo, Gyeonggido KOREA (THE REPUBLIC OF), verified against its source on 2026-10-01.
- Firm
- Oasis Trading verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- KOREA (THE REPUBLIC OF) verified
- Address
- 39-13 Sugi-Ro , Gocheon-Eup , Gimpo, Gyeonggido KOREA (THE REPUBLIC OF) verified
- Date published
- 07/31/2019 verified
- Product code
- 64 E - - 01 Cellulase (Enzyme) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 Y - - 99 Exhibits - Other Drug Related Items N.E.C. each item verified
- Product
- Festal Plus Tablets | Younggaksan Powder | Festal Plus Tablets | Younggaksan Powder each item verified
- FDA notes
- The product appears to be an unapproved new drug as the product contains the active ingredient pancreatin and the product label notes the product's intended use as a digestive aid by listing (not an all-inclusive list); '...Uses; Digestion...'. | The product appears to be an unapproved new drug as the product's label includes disease claims such as (not an all-inclusive list): '...helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive temporarily relieves: cough due to minor throat and bronchial irritation as may occur with common cold or inhaled irritants the intensity of coughing the impulse to cough to help you get sleep...'. | The product appears to be an unapproved new drug as the product contains the active ingredient pancreatin and the product label notes the product's intended use as a digestive aid by listing (not an all-inclusive list); '...Uses; Digestion...'. | The product appears to be an unapproved new drug as the product's label includes disease claims such as (not an all-inclusive list): '...helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive temporarily relieves: cough due to minor throat and bronchial irritation as may occur with common cold or inhaled irritants the intensity of coughing the impulse to cough to help you get sleep...'. each item verified
What the source says
Oasis Trading Date Published : 07/31/2019 39-13 Sugi-Ro , Gocheon-Eup , Gimpo, Gyeonggido KOREA (THE REPUBLIC OF)
— accessdata.fda.gov, retrieved 2026-09-24
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
64 E - - 01 Cellulase (Enzyme) Date Published: 08/05/2019 Desc: Festal Plus Tablets Notes: The product appears to be an unapproved new drug as the product contains the active ingredient pancreatin and the product label notes the product's intended use as a digestive aid by listing (not an all-inclusive list); '...Uses; Digestion...'. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 07/31/2019 Desc: Younggaksan Powder Notes: The product appears to be an unapproved new drug as the product's label includes disease claims such as (not an all-inclusive list): '...helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive temporarily relieves: cough due to minor throat and bronchial irritation as may occur with common cold or inhaled irritants the intensity of coughing the impulse to cough to help you get sleep...'. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 08/05/2019 Desc: Festal Plus Tablets Notes: The product appears to be an unapproved new drug as the product contains the active ingredient pancreatin and the product label notes the product's intended use as a digestive aid by listing (not an all-inclusive list); '...Uses; Digestion...'. 66 Y - - 99 Exhibits - Other Drug Related Items N.E.C. Date Published: 07/31/2019 Desc: Younggaksan Powder Notes: The product appears to be an unapproved new drug as the product's label includes disease claims such as (not an all-inclusive list): '...helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive temporarily relieves: cough due to minor throat and bronchial irritation as may occur with common cold or inhaled irritants the intensity of coughing the impulse to cough to help you get sleep...'.
— all from accessdata.fda.gov, retrieved 2026-09-24
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.